CNTNAP4 and Mental deterioration: A biomimetic microglial nanoparticle system (MNPs@PLX) was established for precise microglial delivery of FDA‐approved PLX3397 to attenuate cognitive decline, dysfunctional synaptic plasticity, and pro‐inflammatory response in female heterozygous Cntnap4 knockout mice.